Get the Stockscreener App
0.4693
28.90%
-0.1908
After Hours:
.49
0.0207
+4.41%
Sunshine Biopharma Inc stock is traded at $0.4693, with a volume of 814.49K.
It is down -28.90% in the last 24 hours and down -51.56% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$0.6601
Open:
$0.56
24h Volume:
814.49K
Relative Volume:
14.36
Market Cap:
$2.30M
Revenue:
$36.31M
Net Income/Loss:
$-5.98M
P/E Ratio:
-0.3161
EPS:
-1.4848
Net Cash Flow:
$-6.17M
1W Performance:
-56.54%
1M Performance:
-51.56%
6M Performance:
-71.21%
1Y Performance:
-66.24%
1-Day Range:
$0.46
$0.589
1-Week Range:
$0.46
$1.14
52-Week Range:
$0.46
$2.43
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-330-0684
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
0.4693 | 3.24M | 36.31M | -5.98M | -6.17M | -1.4848 |
TAK
Takeda Pharmaceutical Co Adr
|
16.63 | 52.58B | 29.85B | 776.90M | 4.35B | 0.2408 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.31 | 42.21B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
8.91 | 39.99B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.48 | 31.17B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
575.79 | 24.60B | 3.17B | 1.29B | 1.01B | 27.09 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
Sunshine Biopharma (SBFM) Q1 2026 results show lower revenue but steady losses - Stock Titan
Sunshine Biopharma stock tumbles on $6 million dilutive offering - Investing.com
Sunshine Biopharma stock tumbles on $6 million dilutive offering By Investing.com - Investing.com UK
MSN Money - MSN
[S-1] Sunshine Biopharma Inc. Files IPO Registration Statement - Stock Titan
SBFM Q1'26 Earnings: EPS estimate is (0.16) USD - TradingView
Sunshine Biopharma Will Be Issued U.S. Patent Number 12,624,066 Tomorrow Titled "INHIBITORS OF CORONAVIRUS PROTEASE (AND USES OF THE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTION)". - Sahm
SBFMW: Sunshine Warrant Reports No Earnings DataTrending Social Stocks - newser.com
The shareholder friendly policies at Sunshine (SBFMW) | SBFMW: Sunshine Warrant Reports No Earnings DataSPAC - newser.com
Number of shareholders of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
SBFMW (Sunshine) outlines targeted oncology pipeline expansion plans in its latest quarterly earnings release.Financial Data - newser.com
SBFM Sunshine Biopharma posts far wider than expected Q4 2025 loss, shares fall 1.37% today.Recovery Stocks - newser.com
How do interest rates affect Sunshine (SBFMW) stock |Senior Analyst Forecasts - newser.com
SBFM Sunshine Biopharma posts wider than expected Q4 2025 loss as shares close unchanged for the trading day.Social Buzz Stocks - newser.com
SBFM Forecast, Price Target & Analyst Ratings | SUNSHINE BIOPHARMA INC (NASDAQ:SBFM) - ChartMill
SBFM (Sunshine Biopharma Inc.) posts wider than expected Q4 2025 loss even as its stock edges higher today. - Xã Thanh Hà
SBFM (Sunshine Biopharma Inc.) rises 3.2 percent despite wider than expected Q4 2025 quarterly per share losses.Hot Momentum Watchlist - Cổng thông tin điện tử tỉnh Tây Ninh
SBFM Financials: Income Statement, Balance Sheet & Cash Flow | Sunshine Biopharma Inc - Stock Titan
Sunshine Biopharma Inc. Warrant (SBFMW) - Minichart
SBFM Director Natan David Acquires 100K Shares – April 15, 2026 - Meyka
Director Natan David receives 100,000 SBFM shares in stock award - Stock Titan
Returns Recap: What is Sunshine Biopharma Incs valuation compared to sector2026 Big Picture & Low Risk Investment Opportunities - baoquankhu1.vn
US Market Recap: Is Sunshine Biopharma Incs ROE strong enough2026 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Smart Money: What is Sunshine Biopharma Incs valuation compared to sectorTrade Exit Report & Verified Momentum Stock Alerts - baoquankhu1.vn
Sunshine Biopharma Posts Modest 2025 Revenue Growth and Tightens Costs to Pursue Profitability - TipRanks
Sunshine Biopharma (NASDAQ: SBFM) details 2025 results and cost cuts - Stock Titan
Is Sunshine Biopharma (SBFM) Stock Good for Portfolio | Price at $1.06, Up 0.95%Breakout Watch - newser.com
SBFM Reports Increased Revenue and Outlines Future Growth Plans - GuruFocus
Sunshine Biopharma (SBFM) Aims for Cost Reductions to Enhance Pr - GuruFocus
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year - ACCESS Newswire
Sunshine Biopharma launched nine new drugs as 2025 sales hit $36.3M - Stock Titan
Sunshine Biopharma Inc. 2025 Annual Report: Generic Drug Portfolio, Proprietary Oncology & Antiviral Developments, and Corporate Strategy - Minichart
SBFM SEC FilingsSunshine Biopharma Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Sunshine Biopharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Sunshine Biopharma (NASDAQ: SBFM) 2025 revenue reaches $36.3M - Stock Titan
Sunshine Biopharma 2025 10-K: $36.3M Revenue, $(1.44) EPS - TradingView — Track All Markets
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
SBFMW Stock Analysis: Sunshine Biopharma Inc Warrant 0.13 Flat Performance Review - newser.com
Aug Reactions: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changesQuarterly Performance Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Sunshine Biopharma Delays Annual SEC Filing - TipRanks
[NT 10-K] Sunshine Biopharma Inc. SEC Filing - Stock Titan
SBFM PE Ratio & Valuation, Is SBFM Overvalued - Intellectia AI
Aug Wrap: Does Sunshine Biopharma Inc Equity Warrant stock have upside surprise potential - baoquankhu1.vn
Bear Alert: What are the future prospects of Sunshine Biopharma Inc Equity Warrant2026 Volume Leaders & Safe Capital Investment Plans - baoquankhu1.vn
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
3.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):